Categories: Sports

India’s Triple-Jumper Aishwarya Babu Banned by NADA for Four Years

India’s top triple-jumper Aishwarya Babu has been banned by the National Anti-Doping Agency’s (NADA) disciplinary panel for four years for using a prohibited anabolic steroid. Aishwarya Babu, 25 years old, was dropped from the Birmingham Commonwealth Games in 2022, along with sprinter S Dhanalakshmi after testing positive for the steroid, which is on the World Anti-Doping Agency’s (WADA) prohibited list.

Aishwarya has been given time till 6th March 2023 to file an appeal against the ban after receiving the ban notice from NADA’s Appeal Panel on 13th February 2023.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

India’s Triple-Jumper Aishwarya Babu Banned by NADA for Four Years – Key Points

  • Aishwarya previously won the triple jump gold in the championships with a national record-breaking lunge of 14.14 meters.
  • She tested positive for Ostarine — a drug that falls in the category of selective androgen receptor modulator (SRAM) —  during the National Inter-State Championships on 13 and 14 J in 2022 in Chennai.
  • Aishwarya was provisionally suspended in July last year and she has already served six months of her four-year ban.
  • NADA stated that the substance Aishwarya used was an “anabolic steroid” listed under WADA’s 2022 prohibited. It added that the athlete had not taken a therapeutic use exemption (TUE) for it.
  • Aishwarya on the other hand stated in her submission that she “did not take any prohibited ton order to enhance” her performance.
  • The athlete added that she had suffered an injury in the past when her shoulder had dislocated while lifting weights in the gym in February 2021.
  • Aishwarya added that in the run-up to the National Inter-state Championships, she pushed herself too much, which led her to the “painful discomfort on the Shoulder.”
  • NADA’s disciplinary panel questioned why Aishwarya did not approach a hospital or a registered medical practitioner for treatment, adding that the athlete “totally disregarded the rule and took Ostathe rine tablets on advice of her colleague.”
  • The athlete has failed to satisfy the panel that the ADRV (Anti-Doping Rule Violation) was non-intentional as per NADA.

Also Read:

Find More Sports News Here

 

 

Mahesh Kumar

Working as an SEO Manager at Adda247, I bring over 10 years of experience in Search Engine Optimization (SEO) and digital marketing. I specialize in driving organic growth through data-driven strategies, including keyword research, on-page SEO, off-page optimization, and technical SEO. My area of expertise in the EdTech sector, specifically focusing on competitive exams such as Bank, SSC, Railway, UPSC, and various State Government job examinations.

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

7 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

7 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

8 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

9 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

9 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

10 hours ago